Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: presents for scheduled surgery major surgical or invasive procedure: partial left thyroid lobectomy tracheostomy placement ct guided liver biopsy history of present illness: ms. is a 60 year old female who presented earlier this year with a smooth symmetric goiter which was causing some compressive symptoms but was totally benign by biopsy and in fact indicative of hashimoto's. she had several things going on in her personal life at that time and by the time surgery was scheduled, she had some increasing shortness of breath and in the last several days, some change in her voice. on exam, the area appeared unchanged and she was brought to the operating room for scheduled surgical resection of her thyroid. past medical history: past surgical history: right hip replacement social history: married, lives with husband, 2 glasses wine/night. nonsmoker family history: family members with benign thyroid disease pertinent results: operative note : goiter with compressive symptoms secondary to advanced aggressive thyroid cancer with invasion of trachea and pharynx. operation: 1. neck exploration. 2. extensive dissection left neck. 3. partial left thyroid lobectomy. operative note : thyroid cancer and respiratory failure. procedures: flexible bronchoscopy and 8-0 portex tracheostomy tube. ct chest : impression: 1) large thyroid mass/phlegmon which encases and narrows the trachea to the diameter of the endotracheal tube extending from the level of the cords to approximately 5 cm above the carina. 2) large enhancing mass located between the left kidney and pancreatic tail. further evaluation with dedicated abdominal imaging is recommended. 3) 2 cm right hepatic lesion which is not fully characterized on this single phase study but most likely represents a hemangioma. ct abdomen/pelvis : impression: 1. 5.0-cm enhancing mass in the left upper quadrant, with necrotic center. the mass lies between the left kidney and pancreatic tail and may arise from the left adrenal gland. although metastasis from thyroid cancer should be considered, additional considerations include primary adrenal neoplasm such as pheochromocytoma (in which case, multiple endocrine neoplasia could be considered). other adrenal neoplasm such as adrenocortical carcinoma could be considered. less likely, considerations are nonfunctioning islet cell tumor related to the pancreas and gastrointestinal stromal tumor. 2. two hypervascular lesions in the liver are concerning for metastases from thyroid cancer. 3. fibroid uterus, with 3.3-cm heterogeneous mass with internal calcifications adjacent to the uterus on the left, which may represent a calcified exophytic fibroid. attention to this area on followup examination is recommended. ct guided biopsy : impression: 1. successful biopsy of the abdominal mass. pathology results are pending. pathology report: thyroid: resection synopsis macroscopic specimen type: left lobe, partial. tumor site: left lobe. tumor focality: extensively involves the left lobe. tumor size (largest nodule): cannot be determined (see comment). microscopic histologic type: poorly differentiated carcinoma, favor follicular carcinoma. see comment. extent of invasion primary tumor: pt4a: tumor more than 4 cm, limited to the thyroid or with minimal extrathyroidal extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues). see comment. regional lymph nodes: pnx: cannot be assessed. lymph nodes number examined: 0. distant metastasis: pmx: cannot be assessed. margins: involved by carcinoma. specified margin: inked tissue edge. venous/lymphatic (large/small vessel) invasion: present. comments: the tumor is a poorly differentiated carcinoma. immunohistochemical studies show the tumor cells are positive for cytokeratin cocktail, ttf-1 and thyroglobulin and are negative for calcitonin. these results confirm the tumor is of thyroid origin. the tumor is felt to be either a poorly differentiated papillary carcinoma or a poorly differentiated follicular carcinoma; the latter is favored. the size of the tumor is difficult to determine as it involves the entire thyroid lobe. the tumor invades into perithyroid soft tissue and, therefore, is at least a pt3 tumor. however, as per the online operative note, the tumor may actually be a pt4 tumor. discharge labs: complete blood count wbc rbc hgb hct mcv mch mchc rdw plt ct 06:45am 6.9 3.64* 11.8* 33.1* 91 32.5* 35.8* 13.4 578* basic coagulation (pt, ptt, plt, inr) pt ptt plt ct inr(pt) 06:45am 578* tsh 03:00am 0.89 thyroid t4 t3 calctbg tuptake t4index free t4 03:00am 6.8 46* 0.90 1.11 7.5 1.2 immunology anti-tg thyrogl 02:42am 2396*1 unable to 2 brief hospital course: ms. was admitted to the surgical service for a scheduled thyroidectomy, intra-operatively she was found to have an advanced aggressive thyroid cancer with invasion of the tracheal and pharynx, final pathology revealed poorly differentiated carcinoma, favor follicular carcinoma, t3/t4. post-operatively she was extubated but developed respiratory distress and stridor; pod 2 she underwent a flexible bronchoscopy and placement of 8-0 portex tracheostomy tube. endocrinology and oncology service were consulted, a ct scan demonstrated no axillary, mediastinal, or hilar lymphadenopathy; there was a retroperitoneal enhancing mass, no bone lesions suspicious for malignancy, and a right hepatic lesion was also seen. the retroperitoneal mass was biopsied prior to discharge home with pathology results pending. she was to follow-up with dr. , oncologist on to discuss chemotherapy treatment options. pod , she was extubated without difficulty and oxygenating well on humidified tracheostomy collar, she was evaluated by speech and swallow therapy and did not demonstrate signs or symptoms of aspiration, her diet was slowly advanced to regular with thin liquids and pills to be taken with whole liquids which she tolerated well. she was also evaluated for a passy-muir valve; she was unable to tolerate the placement and was found to have increase tracheal pressures and reported difficulty exhaling, she was to follow-up as an out-patient for re-evaluation of the pmv. post-operatively she had episodes of delirium and agitation related to diagnosis, tracheostomy, and icu admission; psychiatry was consulted with recommendations of using seroquel at bedtime and haldol. her mental status and coping skills improved dramatically over the course of the hospitalization, at the time of discharge her anxiety was well controlled with small doses of ativan as needed and trazodone at bedtime. she had a supportive family and out-patient psychiatry therapy was offered. throughout her hospitalization she was also followed by respiratory therapy for care of the tracheostomy. she was oxygenating well on a humidified 35% trach. collar while in bed, but could ambulate independently off oxygen without respiratory distress, multi-dose inhaler treatments continued every hours. she was able to change the inner cannula independently and could expectorate her secretions with minimal suctioning required. she was discharged home in stable condition on with visiting nurse services and home respiratory care, all oxygen supplies were to be delivered to her home. she was tolerating a regular diet, afebrile, voiding without difficulty, and ambulating independently. her pain was well controlled with percocet. she was to follow-up with dr. in weeks, oncology , and speech and swallow therapy in weeks. medications on admission: multivitamins discharge medications: 1. albuterol 90 mcg/actuation aerosol sig: 2-4 puffs inhalation q6h (every 6 hours) as needed. disp:*1 unit* refills:*0* 2. ipratropium bromide 17 mcg/actuation aerosol sig: six (6) puff inhalation q4-6h (every 4 to 6 hours) as needed. disp:*1 unit* refills:*0* 3. acetaminophen 325 mg tablet sig: two (2) tablet po q4-6h (every 4 to 6 hours) as needed. 4. docusate sodium 50 mg/5 ml liquid sig: ten (10) ml po bid (2 times a day) as needed for constipation. disp:*100 ml* refills:*0* 5. zolpidem 5 mg tablet sig: 1-2 tablets po hs (at bedtime) as needed for insomnia. disp:*30 tablet(s)* refills:*0* 7. albuterol sulfate 0.083 % (0.83 mg/ml) solution sig: one (1) inhalation q4h (every 4 hours) as needed. disp:*1 unit* refills:*0* 8. ipratropium bromide 0.02 % solution sig: one (1) inhalation q6h (every 6 hours) as needed. disp:*1 unit* refills:*0* 9. lorazepam 1 mg tablet sig: one (1) tablet po q6h (every 6 hours) as needed for anxiety. disp:*20 tablet(s)* refills:*0* 10. oxycodone-acetaminophen 5-325 mg tablet sig: 1-2 tablets po q4-6h (every 4 to 6 hours) as needed for pain: take with food do not take with ativan. disp:*20 tablet(s)* refills:*0* 11. oxygen 28%-50% sig: 28%-50% oxygen continous. disp:*1 tank* refills:*2* 12. stationary suction/portable suction sig: with yankower catheter once a day: and 14fr suction catheters. disp:*99 box* refills:*2* 13. 8 portex with #8 inner cannula sig: one (1) four times a day. disp:*99 cannulas* refills:*2* 14. cool mist compressor sig: with 02 titration continuous. disp:*1 tank* refills:*2* 15. speech and swallow evaluation sig: passy-muir valve please evaluate for passy-muir valve: pt. with unresectable thyroid cancer and tracheostomy. disp:*1 0* refills:*0* 16. trazadone 25-50mg qhs prn discharge disposition: home with service facility: med services discharge diagnosis: thyroid carcinoma tracheostomy abdominal mass discharge condition: stable discharge instructions: notify md or return to the emergency department: *increased or persistent pain *fever > 101.5 *shortness of breath, difficulty clearing secretions, or mucus plug *increased secretions, inability to clear secretions, or change in character of secretions *inability to swallow or breath *if incisional/tracheostomy site develops redness or drainage *if biopsy site develops redness, bruising, or bleeding *inability to pass gas, stool, or urine *nausea, vomiting, diarrhea, or abdominal distention that lasts longer than 24 hours *chest pain or palpitations *any other symptoms concerning to you you may shower, be careful with tracheostomy and try to avoid water from entering the opening no swimming slowly increase your daily activities including walking throughout the day please keep all scheduled appointments followup instructions: provider: , md, phd: date/time: 3:00 follow-up with dr. in weeks, call for an appointment follow-up with dr. (cardiothoracic surgeon who placed tracheostomy) if there are any problems or difficulties with the tracheostomy, call for an appointment follow-up for speech and swallow therapy, and possible evaluation for a passy-muir valve, they will contact you for an out-patient appointment procedure: continuous invasive mechanical ventilation for less than 96 consecutive hours insertion of endotracheal tube enteral infusion of concentrated nutritional substances other bronchoscopy temporary tracheostomy biopsy of lymphatic structure other partial thyroidectomy radical neck dissection, unilateral diagnoses: anxiety state, unspecified acute respiratory failure other isolated or specific phobias secondary and unspecified malignant neoplasm of intra-abdominal lymph nodes other diseases of trachea and bronchus malignant neoplasm of thyroid gland 

Answer: The patient is high likely exposed to